
    
      The efficiency of lipid lowering therapy was already proven by the clinical trials of
      statins. According to these results, the target value of LDL-C is recommended under 100mg/dL
      in the Japan Atherosclerosis Society Guidelines. However, the efficiency of intensive therapy
      to lower LDL-C more than 100mg/dL has not been proven yet.
    
  